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potassium channelPolyunsaturated fatty acids (PUFAs) and theirmetabolites canmodulate several biochemical processes in the cell
and thus prevent various diseases. PUFAs have a number of cellular targets, including membrane proteins. They
can interact with plasmamembrane and intracellular potassium channels. The goal of thisworkwas to verify the
interaction between PUFAs and the most common and intensively studied mitochondrial large conductance
Ca2+-regulated potassium channel (mitoBKCa). For this purpose human astrocytoma U87 MG cell lines were in-
vestigated using a patch-clamp technique. We analyzed the effects of arachidonic acid (AA); eicosatetraynoic
acid (ETYA), which is a non-metabolizable analog of AA; docosahexaenoic acid (DHA); and eicosapentaenoic
acid (EPA). The open probability (Po) of the channel did not change signiﬁcantly after application of 10 μM
ETYA. Po increased, however, after adding 10 μM AA. The application of 30 μMDHA or 10 μM EPA also increased
the Po of the channel. Additionally, the number of open channels in the patch increased in the presence of 30 μM
EPA. Collectively, our results indicate that PUFAs regulate the BKCa channel from the inner mitochondrial
membrane.48 22 8225342.
.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Polyunsaturated fatty acids (PUFAs) are integral, structural compo-
nents of the phospholipid bilayer of cell membranes. Conditions that
promote the accumulation of PUFAs, such as brain ischemia, increase
the level of extracellular and intracellular PUFAs [1]. One such critical
metabolic event during ischemia is the activation of PLA2 due to an
increased concentration of intracellular Ca2+ ions [2]. This activation
results in the hydrolysis of membrane phospholipids and the release
of free fatty acids, particularly arachidonic acid (AA).
A growing body of evidence suggests that ischemic preconditioning,
short episodes of ischemia that increase tissue tolerance to lethal
insults, could be mimicked by the administration of openers of mito-
chondrial K-channels [3,4]. The transport of K+ ions into the mito-
chondrial matrix can trigger the protection of the injured cardiac
and neuronal tissues. It has been suggested this transport causes
changes in the volume of the mitochondrial matrix [4], the inner
membrane potential [5], the rate of generation of reactive oxygen
species [6], and the inﬂux of Ca2+ [7]. These changes most likely occur
to protect the cell from death [8]. The ATP-regulated K-channels and
the mitoBKCa are among the best-described channels in the innermitochondrial membranes and also play roles in cytoprotection.
The mitoBKCa was initially described in human glioma cells [9].
Later, it was identiﬁed in inner mitochondrial membranes of guinea
pig ventricular cells [10], skeletal muscles [11], rat astrocytes [12],
and, recently, in neuronal cells [13].
Neuronal and glial cells respond to ischemic injury in differentways.
We have focused on astrocyte-type cells, which are less vulnerable to
ischemic brain damage than the neighboring neurons are [14]. One of
the protective functions of astrocytes during ischemia is the uptake of
glutamate, thus limiting the excitotoxic injury to the neighboring
neurons [15]. Astrocytes also provide neurons with antioxidants,
such as glutathione. The neurons are thought to be the cells that
are most vulnerable to ischemia. This conclusion is based primarily
on the observation that astrocyte cultures exhibit greater resistance
to some ischemia-like insults than neurons do [16].
One target of ischemic injury is the mitochondrion. Interestingly,
mitochondrial dysfunction in astrocyte cells reduced their ability to
protect neurons against glutamate toxicity. The inhibition of astrocyte
mitochondria by ﬂuorocitrate has been shown to increase the neuronal
sensitivity to ischemia [17].
The role of the mitochondria in ischemic preconditioning has been
studied in the heart and in the brain. During ischemia degradation of
phospholipids occurs in the mitochondrial membranes [18]; therefore,
one action of PUFAs or theirmetabolites, namely, the regulation of intra-
cellular ion channels, was investigated within these membranes.
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fatty acids (FAs) are modulating the mitoBKCa activity. We examined
the inﬂuence of PUFAs on mitochondrial channels for the following
reasons: (1) differences in the PUFA levels have been found in patients
with variousneurological disorders, especially duringbrain ischemia [19];
(2) PUFAs may display cell-protective properties [20,21]; (3) PUFAs are
able to modulate mitochondrial functions, such as oxygen consumption
[22], mitochondrial swelling [23], reactive oxygen species production
[24], cytochrome c release [25], and permeability transition [26]; and
(4) FAs are able to interact with the BKCa from the plasma membrane
[27,28].
2. Materials and methods
2.1. Human astrocytoma U87MG cell line
The short tandem repeat (STR) proﬁling technique was performed
according to the guidelines published recently [29,30]. Brieﬂy, our
cells were expanded and frozen at 90% conﬂuence during the expo-
nential growth phase and sent for STR proﬁling analyses to the
German Collection of Microorganisms and Cell Cultures [Leibniz
Institut Deutsche Sammlung für Mikroorganismen und Zellkulturen
(DSMZ), Braunschweig, Germany]. STR DNA proﬁling was carried
out using ﬂuorescent PCR in combinationwith capillary electrophoresis
as described previously [31]. Using different alternate colors, the
PowerPlex VR 1.2 system (Promega,Mannheim, Germany)wasmodiﬁed
in order to run a two-color DNA proﬁling allowing the simultaneous
single-tube ampliﬁcation of eight polymorphic STR loci and Amelogenin
for gender determination. STR loci of CSF1PO, TPOX, TH01, vWA and
Amelogenin were ampliﬁed by primers labeled with the Beckman/
Coulter dye D3 (green; Sigma-Aldrich, Munich, Germany), while the
STR loci D16S539, D7S820, D13S317 and D5S818 were ampliﬁed using
primers labeled with D2 (black). All the loci except the Amelogenin
gene in this set are true tetranucleotide repeats. All primers are identical
to the PowerPlex VR 1.2 system except the ﬂuorescent color. Data were
analyzed with the CEQ 8000 software (Beckman-Coulter, Krefeld,
Germany), which enables an automatic assignment of genotypes and
automatic export of resulting numeric allele codes into the reference
DNA database of the DSMZ [32].
2.2. Preparation ofmitochondria from human astrocytoma U87MG cell line
Human astrocytoma cells were cultured in DMEM as described else-
where [12]. After loosening the cells by trypsin, the solution was gently
removed, and the cells were washed with CMF (Ca2+-Mg2+-free
solution). The loosened cells were dispersed in DMEM and centrifuged
at 800 ×g for 10min. The pellet was resuspended in a preparation so-
lution (250mM sucrose, 5mMHEPES, pH 7.2) and homogenized. The
homogenatewas centrifuged at 9200 ×g for 10min, resuspended in the
preparation solution, and centrifuged at a low speed (790 ×g) for
10 min to separate the fraction of puriﬁed mitochondria. The
preparation solution containing sucrose was removed by two fast
centrifugations (9200 ×g for 10 min) in the storage solution (150 mM
KCl, 10 mM HEPES, pH = 7.2). The mitoplasts (mitochondria without
the outer membrane) were prepared from the mitochondria by the
addition of a hypotonic solution (5 mM HEPES, 100 μM CaCl2, pH =
7.2) to induce swelling, which was followed by the rupture of the
outer membrane. Isotonicity was restored by adding a hypertonic
solution (750 mM KCl, 30 mM HEPES, 100 μM CaCl2, pH = 7.2).
2.3. Patch-clamp measurements
An isotonic solution (150mMKCl, 10mMHEPES, and 0.1mMCaCl2;
pH = 7.2) was used as the control solution for all of the experiments.
The external Ca2+ concentration of the mitoplast (i.e., inside the patch
pipette) was 0.1 mM in the isotonic solution. The isotonic bath solutionhad a Ca2+ concentration of 0.2 mM or 0.1 mM. The inward current
always deﬂects downward, and the holding potentials (Eh) at the
inner side of the membrane are reported. Stock solutions of arachidonic
acid, eicosatetraynoic acid, docosahexaenoic acid and eicosapentaenoic
acid were made in 99% ethanol. The oxygen contained in the stock
solutions was removed by nitrogen bubbling. Before running each
experiment concentrated stock solutions were diluted in nitrogen-
bubbled isotonic solution to a ﬁnal concentration (test solution).
Air bubbles were removed from the isotonic bath solution, isotonic
solution in the measured pipette and test solutions pumped by a
peristaltic pump-driven capillary-pipe system.
2.4. Data analysis
Data were analyzed using the pClamp10 software package. Events
shorter than 0.5 ms were ignored. The conductance was calculated
from the current–voltage characteristics. The open probability of the
channel (Po) was determined using the single-channel mode of the
Clampﬁt10 software. The data are reported as the mean ± SEM
(standard error of the mean). Student's t test was used to evaluate
the signiﬁcant differences between two groups, and p b 0.05 was
considered statistically signiﬁcant (in ﬁgures marked by asterisk).
3. Results
3.1. Patch-clamp experimental conditions and controls
The mitoplast-attached patches obtained from human astrocytoma
mitochondria were examined to determine the kinetic properties of
the mitoBKCa after application of the FAs. First, the patches were
exposed to isotonic solutionswith different Ca2+ concentrations ranging
from a low level (i.e., without added Ca2+ or Ca2+ chelators, which
means μM concentrations due to impurities from the other chemicals
and the glassware) to a maximum of 200 μM. We observed channel
features similar to those previously reported in astrocytes [12], which
are characteristic of a large-conductance calcium-activated K-channel
(mitoBKCa). Patches with an appropriate seal resistance that exhibited
mitoBKCa activity were obtained 53 times in 41 mitochondrial prepara-
tions. In some cases,we recorded two or threemitoBKCa channelswithin
a single patch. The single-channel recordings obtained at Eh =+20mV
are presented in Fig. 1A.
To exclude the possibility that the measured current was caused by
another type of mitochondrial K-channel, we used inhibitors that are
commonly known to block mitoBKCa, such as iberiotoxin and paxilline
(Fig. 1A). Occasionally, the measured channel exhibited a smaller cur-
rent than that of the fully open state. Due to both, the behavior observed
in the blocking experiments and the voltage dependence of the current
observed for these channels, we identiﬁed this current as a substate of
the fully open mitoBKCa. We also controlled the Ca2+ dependence of
the channel by replacing the isotonic solution containing 200 μM Ca2+
with an isotonic solution containing either 100 μM Ca2+ or no added
Ca2+ ions (referred to as low Ca2+ in the manuscript). Fig. 1A shows
the controls that were prepared at the start of the experiments. The
application of an isotonic solution containing either 100 μM Ca2+ or
10 μM Ca2+ decreased the Po of the channel. Similarly, single-channel
recordings performed under control conditions (200 μM Ca2+) and
low-Ca2+ conditions revealed the dependence of the channel activity
on the Ca2+ concentration. Moreover, we demonstrated that the
complete removal of Ca2+ ions by the addition of 50 μM EGTA to the
external isotonic solution blocked the channel activity completely but
reversibly.
After characterizing the mitoBKCa properties, we studied the
effect of FAs on the channel in the presence and absence of Ca2+
ions. To investigate the possible effects of FAs on the mitoBKCa, we
ﬁrst determined how fast the channel responded to the external
application of FAs. The effects of the FAs appeared after 3–4 min
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fect under the simultaneous control of the Ca2+ response of the
mitoBKCa. The different FA- or Ca2+-containing solutions were
added in a speciﬁc order. The experiment was divided into seven
parts, each lasting 7 min (Fig. 1C). If possible, blockers of the mitoBKCa
were added at the end of the experiments. The location of the patch
pipette with the attached mitoplast inside the pipe of the perfusion
system is shown in Fig. 2A. Not surprisingly, increased concentrations
of FAs (10 μM, 30 μM, and 100 μM) decreased the electrical resistance
of the mitochondrial membrane as demonstrated in Fig. 2B. This
decrease in the resistance occurred almost linearly (Fig. 2C). Occasionally,
the highest FA concentrations caused the loss of the patch. Because FAs
are known to be oxidized by oxygen, the stock solutions of all of the
FAs and the daily preparations of the isotonic solutions were bubbledFig. 1. Identiﬁcation of the mitoBKCa channel by single-channel recording in mitoplasts from hu
acids. (A) Left panel shows Ca2+-dependence and sensitivity to iberiotoxin and paxilline, inhib
(control) and, thereafter, 100 μM Ca2+, 10 μM Ca2+, 50 μM EGTA, low Ca2+ concentration (w
state, dotted lines the fully open state, Eh = +20 mV. Recordings are from one representativ
(±SEM, n = 14). (B) Time course of Po of the mitoBKCa reveals that arachidonic acid slowly in
acid. Recordings are from one representative out of three independent experiments. (C) Patc
dependence of the channel we started in isotonic solution (200 μM Ca2+) then switching to iso
concentrations of fatty acids (10 μM, 30 μM, and 100 μM) and ﬁnally tested washout of fatty aci
blockers (paxilline, iberiotoxin) thereafter.with nitrogen. Fig. 2D shows that 10 min of nitrogen bubbling applied
to the isotonic solutions had no effects on the channel activity.
3.2. mitoBKCa sensitivity to arachidonic acid, n-3 PUFA
As the ﬁrst step of the experiments, we examined the effect of
arachidonic acid on the mitoBKCa activity. It is known that AA is
released from the membranes during ischemia and can interact
with plasma membrane K-channels ([20,33]; depicted in Fig. 3A).
To study whether Ca2+ ions play a role in the effect of AA on the
mitoBKCa, AA was tested in isotonic solutions with either low or
high Ca2+ concentrations. The application of 10 μM AA in an isotonic
solution containing 100 μM Ca2+ did not signiﬁcantly alter the channel
conductance (data not shown), but it increased the Po (Fig. 3B). Thisman astrocytoma cells and schematic description of the experiments with the use of fatty
itors of the mitoBKCa. Symmetrical (150/150 mM KCl) solutions containing 200 μM Ca2+
ithout added Ca2+), 10 μM paxilline and 100 nM iberiotoxin. Dashes indicate the closed
e out of three independent experiments. Right panel shows mean open probability (Po)
creased Po. Control: isotonic solution (100 μM Ca2+). AA: control plus 10 μM arachidonic
h-clamp experiments were performed in seven parts of 7 min each. For control of Ca2+
tonic solution (100 μM Ca2+ or low Ca2+). Next, we applied test solutions with increasing
ds in control solution. In sufﬁciently stable patches the channels were inhibited by speciﬁc
Fig. 2. Stability of the patch during the external perfusion with diluted fatty acids proves the integrity of the membrane. (A) Sketch of a patch pipette with a mitoplast in the mitoplast-
attached mode. It was moved into different pipes of the ﬂow system. (B) Patch resistance after adding 10 μM, 30 μM and 100 μM fatty acids. Data from twenty-one independent
experiments. Resistance was determined using the pClamp10 software in the Ω0-mode. (C) Single-channel recordings at +20 mV in symmetric (150/150 mM KCl) solution containing
100 μM fatty acid. Recordings are demonstrating the decreasing resistance of the patch (declining baseline) after application of the fatty acid (example after treatment of AA). An
unchanged current amplitude of the channel indicates stable Eh. (D) Representative current traces before and after application of isotonic solution bubbled with nitrogen for 10 min.
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Fig. 3D, left panel). We also tested the AA action in an isotonic solution
with a low Ca2+ concentration. We found that the addition of 10 μM or
30 μMAAdid not alter the current amplitude (data not shown) or the Po
(Fig. 3D, right panel). An increase of the Po appeared only after the
addition of 100 μM AA. These data suggest that the action of AA is
Ca2+ dependent. AA can affect ion channels either directly or by its en-
zymatic or non-enzymatic metabolites. The non-enzymatic metabolites
of AA can be produced by oxygenation. To exclude the possibility that
superoxide anions are responsible for the activation of AA,we examined
the effect of AA in the presence of superoxide dismutase (SOD). SOD
added alone (data not shown) or in parallel with AA changed neither
the channel amplitude nor the conductance (Fig. 3C, D). To analyze
the secondpossibility of AA action via its enzymatic products,we decided
to use a non-metabolizable analog of AA, eicosatetraynoic acid (ETYA).
ETYA has four triple bonds in the 20-carbon chain and it is also an inhib-
itor of cyclooxygenase and of lipoxygenase. The application of 10 μM
ETYAdid not affect themitoBKCa.With the control solution and a solution
containing 10 μMETYA, the single-channel current traceswere compara-
ble (Fig. 4A). The channel amplitude was unchanged (data not shown),
and the Po at Eh = +20 mV was not signiﬁcantly changed (Fig. 4B).
Additionally, we made the same routine control as in experiments with
the used of AA. The co-application of SOD with ETYA, as shown in
Fig. 4C, had the same effect as application of ETYA alone. In summary,
the results from the experiments suggest that AA cause reversibly
mitoBKCa channel activation and the oxidative products of AA do not
play a role in this activation. Moreover mitoBKCa channel is insensitive
to ETYA, a fatty acid known as AA non-metabolizable analog.3.3. mitoBKCa-sensitivity to 4-hydroxynonenal
To investigate whether the effect of AA on the mitoBKCa depends on
some products of AAmetabolism, we conducted experiments using the
ﬁnal product of AA peroxidation. The primary products of these
reactions are reactive aldehyde species, such as trans-4-hydroxy-2-
nonenal (4-HNE). Fig. 5A presents the general peroxidation products
of PUFAs and the biological effects of these products. Fig. 5B depicts
current records showing that the application of 10 μM 4-HNE did not
mimic the channel amplitude. Additionally, the data summarized in
Fig. 5C show that the open probability at Eh = +20 mV was not
signiﬁcantly affected. In summary, our results suggest that the AA-
induced stimulation of the mitoBKCa is not mediated by the ﬁnal
product of AA peroxidation.
3.4. mitoBKCa-sensitivity to docosahexaenoic acid and eicosapentaenoic
acid, n-6 PUFAs
After demonstrating AA effect on themitoBKCa channel, we examined
the effect of other PUFAs. First, we used the docosahexaenoic acid (DHA).
The application of 10 μM, 30 μM, and 100 μMDHA in an isotonic solution
containing 100 μM Ca2+ did not signiﬁcantly alter the Po or the current
amplitude of the mitoBKCa (Fig. 6A). Fig. 6A depicts channel recordings
of the control with 100 μM Ca2+ and after application of 10 μM and
30 μM DHA. In an isotonic solution without Ca2+, but under other-
wise unchanged conditions, the Po of the channel increased in a
dose-dependent manner after the application of 10 μM, 30 μM, and
100 μM DHA (Fig. 6B). This effect was reversible and statistically
Fig. 3. The n-3 PUFA-arachidonic acid (AA) increases Po of the mitoBKCa with andwithout Ca2+ ions. (A) Mechanism of AA release from the plasmamembrane during ischemia. Ischemia
promotes intracellular Ca2+ accumulation and activation of phospholipases (PLA2). PLA2 promotes the release of AA from the membranes which then interact with ion channels.
(B) Recordings at +20 mV in symmetrical (150/150 mM) KCl solutions (control, 100 μM Ca2+), after application of 10 μM AA, and after washout without AA. Dashes indicate closed
state. Dotted lines indicate current amplitudes of two mitoBKCa channels present in this patch. Recordings are from one representative out of four independent experiments.
(C) Current traces before and after application of 10 μM AA plus 100 U/ml superoxide dismutase (SOD). Recordings obtained from one representative out of three independent
experiments. (D) Bar graphs summarizing the effect of AA on the mitoBKCa. Changes of the Po of the mitoBKCa after adding increasing concentrations of AA in the absence (n = 4) and
in the presence of Ca2+ (n = 3). Mean values of independent experiments are indicated (±SEM), *p b 0.05.
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eicosapentaenoic acid (EPA). Our preliminary experiments in isotonic
solutionswith 100 μMCa2+produced the same results as those obtained
with DHA; speciﬁcally, no channel activation or inhibition was observed
(data not shown). Surprisingly, after the EPA application in a low-Ca2+
solution, the mitoBKCa channel responded in two ways. In half of the
experiments, 10 μM EPA increased the Po of the channel signiﬁcantly
and reversibly (Fig. 7A) (p b 0.05, n = 3), and in the other half of the
experiments, there was no signiﬁcant response (Fig. 7B).4. Discussion
Our studies are the ﬁrst to reveal the presence of a PUFA-regulated
BKCa in the inner mitochondrial membrane of human astrocytoma
cells. The major ﬁndings of our investigation are as follows: (1) the
mitoBKCa is sensitive to 10 μM AA in isotonic solutions with high Ca2+
concentrations (at low Ca2+ concentrations, only the addition of
100 μM AA is sufﬁcient to activate the channel); (2) the mitoBKCa is
insensitive to 10 μM ETYA and 4-HNE (10 μM to 100 μM); (3) the ox-
idative products of AA do not play a role in the activation of the
mitoBKCa; and (4) the mitoBKCa is activated by DHA and EPA only
at low Ca2+ concentrations.PUFAs can modulate a variety of K-channels from the plasma
membrane. These PUFAs may act via directly binding to a channel
protein or to an auxiliary protein that regulates the channel. Another
possibility is that PUFAs alter the mechanical properties of the lipid
bilayer after their insertion into the membrane. This latter type of
regulation and the regulation of K-channels via the metabolic products
of FAs are indirect forms of regulation. Based on the literature, there
does not appear to be a general mechanism of PUFA action on the K-
channels of the plasma membrane.
Because the effects of the FAs onmitoBKCa channel were observed in
our experiments only after 3–4 min, we could speculate that the effect
depends on the indirect mechanism. FAs with different potencies to
change the membrane structure should be evaluated using the patch-
clamp technique to test their ability to modulate the mitoBKCa. Based
on research involving GH3 cells [27], it has been concluded that there
is no correlation between the ability of a FA to change membrane
ﬂuidity and its ability to alter the activity of the BKCa. Following the
application of ETYA, a smaller change inmembraneﬂuiditywas observed
than that observed following the application of AA. However, the change
in the Po values was not in accordance with this effect [27].
The next problem is that FAs can ﬂip across the plasma membrane;
thus, it is difﬁcult to localize the site of their action. The BKCa channels
from airway smooth muscle cells [34] and from rabbit pulmonary
Fig. 4.Non-metabolizable analog of arachidonic acid, eicosatetraynoic acid (ETYA) has no signiﬁcant effect on themitoBKCa in the presence of Ca2+. (A) Single-channel recordings at Eh=
+20mV in symmetrical (150/150mM)KCl solutions containing 100 μMCa2+ (control), in isotonic solution containing 100 μMCa2+plus 10 μMETYA, and in controlwith 100 μMCa2+but
without ETYA. Dashes indicate closed state. Dotted lines indicate current amplitude of the fully open state. Recordings are from one representative out of four independent experiments.
(B) Bar graph demonstrating that ETYA has no effect on the Po of the mitoBKCa in the presence of Ca2+. Mean values of independent experiments are indicated (±SEM, n = 4).
(C) Representative current traces recorded before and after the application of 10 μMETYA plus 100 U/ml SOD. Recordings from one representative out of three independent experiments.
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plied to the extracellular side of the membrane. In GH3 cells, the oppo-
site phenomenon has been observed; speciﬁcally, the BKCa was activeFig. 5. The lastmetabolic product of arachidonic acid, 4-hydroxynonenal (4-HNE) has no signiﬁcan
diffuse into the cytoplasm resulting in protein modiﬁcation that causes altered protein activity. A
current of the mitoBKCa with 100 μM Ca2+ plus different concentrations of 4-HNE. Recordings are
missing effect of different 4-HNE concentrations on the Po after adding 10 μM, 30 μM, and 100 μMwhen the AA co-enzyme was applied from the cytosolic side [27]. This
latter effect was also observed with the small-conductance K-channel
from the smooth muscle cells of the toad stomach [35]. Sucht effect on themitoBKCa in the presence of Ca2+. (A) The lipid peroxidation product 4-HNE can
dditionally, 4-HNE can form adducts with DNA, resulting in mispairing. (B) Single-channel
from one representative out of four independent experiments. (C) Bar graph demonstrating
4-HNE. Mean values of independent experiments are indicated (±SEM, n = 4).
Fig. 6. The n-6 PUFA-docosahexaenoic acid (DHA) increases the Po of themitoBKCa only in the absence of Ca2+. (A) Left panel shows recordings in symmetrical (150/150mMKCl) solution
(control, +100 μM Ca2+), and in isotonic solutions (+100 μMCa2+) containing 10 μM and 30 μMDHA. Eh =+20mV. Recordings are from one representative out of three independent
experiments. Right panel shows mean Po (±SEM, n = 3). (B) Left panel shows recordings under the same conditions as in A but without added Ca2+, and after application of isotonic
solutions with 10 μM, 30 μM, and 100 μM DHA. Recordings from one representative out of three independent experiments. Right panel shows mean Po (±SEM, n = 3). Closed state in
A and B indicated by dashes; dotted lines indicate current amplitude of the fully open state. *p b 0.05.
1608 A. Olszewska et al. / Biochimica et Biophysica Acta 1837 (2014) 1602–1610discrepanciesmay indicate amore directmechanismof FA action rather
than a nonspeciﬁc change in the membrane environment. Finally, the
action of PUFAs may depend on the Ca2+ concentration. Due to the
strong negative membrane potential the mitochondrial matrix physio-
logically contains many more Ca2+ ions than the intermembrane
space does. The Ca2+ binding site of the mitoBKCa is located on the
inner site of the membrane. As Fig. 6 shows a less pronounced DHA ef-
fect at high [Ca2+] a directmodulation of themitoBKCa by PUFAs appears
to be more likely.
Conversely, certain structural features of the FAs enable the FAs
to interact with the plasmalemmal BKCa. These structural requirements
include the length of the carbon chain, the number of unsaturated
bonds, the protein conformation, and the charge [27,28]. Horimoto et al.
observed that FAs with more than two double bonds are able to activate
K-channels from cortical neurons [36]. Similar observations were de-
scribed for the BKCa fromgastricmyocytes [37]. Collectively, these results
again support the idea of the direct regulation of the channel by FAs.
K-, Na-, Ca-, and Cl-channels are all modulated either by AA directly
or by one of the metabolites of AA [33]. Our results indicate for the ﬁrsttime that themitoBKCa is sensitive to AA. The addition of ETYA, which is
a non-metabolizable AA analog, did not cause a signiﬁcantly different
effect on the channel. This should incline us to the conclusion that AA
effect is indirect, but it is too far-reaching conclusion and needs further
evidence.
We also considered the fact that the effect of the PUFAs may be due
to the formation of reactive oxygen species. Based on a review of the
literature, we know that the skeletal muscle BKCa, when incorporated
into artiﬁcial membranes or expressed in oocytes, displays a decreased
number of active channels and a reduced Po when exposed to hydrogen
peroxide [38]. Thus, we used a free radical scavenger together with AA
or ETYA (Figs. 4, 5). Our data suggest that the oxidation products of
AA are not involved in the activation of the mitoBKCa.
To further test the hypothesis that the action of the mitoBKCa is
modulated by themetabolic products of AA, we performed experiments
using 4-HNE. ROS produced by themitochondrial respiratory chain and
the products of the metabolism of AA by LOX can react with the double
bonds of the FAs to produce peroxides, such as unsaturated aldehydes
[39]. 4-HNE is a toxic product of the peroxidation of membrane
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cytochrome c oxidase [41] can induce mitochondrial uncoupling via
the uncoupling protein, UCP [42]. This mild uncoupling limits the
production of ROS in the mitochondria. Therefore, we attempted
to determine whether this mild uncoupling may also be due to the in-
teraction of FAs with mitochondrial K-channels. Neither the addition
of 10 μM 4-HNE nor the addition of higher concentrations of 4-HNE
(30 μM and 100 μM) altered the Po of the mitoBKCa. Since mitoBKCa
was insensitive to the ﬁnal peroxidation product of AA metabolism,Fig. 7. The n-6 PUFA - eicosapentaenoic acid (EPA) inhibits the Po of the mitoBKCa in the pres
150mM) KCl solution (control)with low Ca2+-concentration, and in solutionswith 10 μMand
experiments. Right panel showsmean Po (±SEM; n=5) under the same conditions. (B) Left pa
isotonic solutionswith 10 μM, 30 μM, and 100 μMEPA. Recordings from one representative out
same conditions. Dashes in A and B indicate closed state. Dotted lines indicate amplitude of ththe effect of AA must be either direct or connected with other products
of AA metabolism.
The other FAs that we analyzed are the cell-protective n-3 PUFAs,
such as DHA and EPA. Several reports describe the protective effect of
DHA in ischemia and spinal cord injury. Unfortunately, the protective
mechanism is not yet understood. Treatment with DHA reduced the
total infarct volume and potentiated the synthesis of neuroprotectin
D1 (NPD1) in the penumbra following focal cerebral ischemia [21].
The administration of DHA also reduced the occurrence of brainence of a low Ca2+. (A) Left panel shows single-channel recordings in symmetric (150/
30 μMEPA. Eh=+20mV. Recordings are from one representative out of ﬁve independent
nel shows recordings under the same conditions described in A butwith a low Ca2+ and in
of three independent experiments. The right panel shows the Po (±SEM, n= 3) under the
e fully open state(s). *p b 0.05.
1610 A. Olszewska et al. / Biochimica et Biophysica Acta 1837 (2014) 1602–1610infarction and edema. Treatment of the hippocampal tissue with DHA
has a neuroprotective effect [21]. DHA activates the BKCa current in rat
coronary arterial smooth muscle cells [43]. EPA provides protective
effects following brain ischemia, inhibits the inﬂammatory reaction
and oxidative damage, and prevents memory impairment [25]. Denson
and co-workers demonstrated that EPA and all FAs containing cisdouble
bonds are able to activate the BKCa from the GH3 cell line. Following the
application of 10 μM to 100 μM DHA, the open probability of the
mitoBKCa increased in a dose-dependent manner. Interestingly, the
application of EPA causedmitoBKCa activation in half of the experiments
and had no effect in the other experiments.
The results presented here may have implications under certain
pathophysiological conditions. Deregulated lipidmetabolism in the cen-
tral nervous systemwas observed in patients with various neurological
disorders. Membrane lipid degradation was shown to be an important
factor contributing to cell damage. Furthermore, the cells that undergo
ischemia were found to have an elevated level of free FAs. There is
also a strong link between mitochondrial function and the presence
of PUFAs. Therefore, we investigated the inﬂuence of FAs on cell-
protective mitochondrial K-channels.
Collectively, our experiments indicate that the observed large-
conductance calcium-activated potassium channel from human astro-
cytoma U87 MG cells is sensitive to arachidonic acid or enzymatic
metabolites of arachidonic acid. Furthermore, the channel is sensitive
to eicosapentaenoic acid and docosahexaenoic acid.
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